Canature Health Technology Co., Ltd.

Equities

300272

CNE1000018L9

Environmental Services & Equipment

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
5.24 ^CNY	+0.96%		+2.14%	-15.48%

Apr. 22	Canature Health Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	CI

Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it has received CNY 410.464 million in funding from a group of investors

May 29, 2022

On May 30, 2022, Shanghai Origincell Biological Cryo Equipment Co., Ltd. closed the transaction. On the same date, the company received CNY 309,464,000 in its second and final tranche. The transaction also included participation from existing investor Shanghai Gaosen Asset Management Co., Ltd.

Latest news about Canature Health Technology Co., Ltd.

Canature Health Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.	Apr. 01	CI
Canature Health Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	Feb. 05	CI
Canature Health Technology Co., Ltd. authorized a Buyback Plan	Feb. 03	CI
Canature Health Technology Co., Ltd. Announces Special Profit Distribution Proposal for 2023, Payable on 24 January 2024	Dec. 29	CI
Canature Health Technology Co., Ltd. completed the acquisition of 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) on November 27, 2023.	Nov. 26	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-22	CI
Canature Health Technology Co., Ltd. agreed to acquire additional 12.87% stake in Shanghai Origincell Biological Cryo Equipment Co., Ltd. from Shanghai Senba Investment Center (Limited Partnership) and Shanghai Senlu Investment Center (Limited Partnership) for CNY 270 million.	23-10-09	CI
Zhuzhou Century Fengyuan Intelligent Technology Co., Ltd. completed the acquisition of additional 40.98185% stake in Spring Water Equipment Manufacturing Co., Ltd. from Canature Health Technology Co., Ltd..	23-09-19	CI
Zhuzhou Century Fengyuan Intelligent Technology Co., Ltd. signed share transfer agreement to acquire additional 40.98185% stake in Spring Water Equipment Manufacturing Co., Ltd. from Canature Health Technology Co., Ltd. for CNY 28.1 million.	23-08-22	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
Canature Health Technology Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023	23-05-24	CI
Canature Health Technology Co., Ltd. Announces Board Elections	23-05-22	CI
Canature Health Technology Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-22	CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	23-05-07	CI
Canature Health Technology Group Co., Ltd.'s Equity Buyback announced on May 16, 2022, has closed with 5,467,100 shares, representing 0.97% for CNY 31.37 million.	23-05-04	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	23-04-03	CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	23-01-04	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Tranche Update on Canature Health Technology Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	22-10-11	CI
Canature Health Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
Tranche Update on Canature Health Technology Group Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	22-07-04	CI
Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it has received CNY 410.464 million in funding from a group of investors	22-05-29	CI

Chart Canature Health Technology Co., Ltd.

Duration

Period

Chart Canature Health Technology Co., Ltd.

More charts

Company Profile

Canature Health Technology Co Ltd is a China-based company mainly engaged in the manufacturing of water treatment products. The Company is committed to the research, development, manufacturing, sales and services of residential water treatment products and core components such as whole-house water purifiers, whole-house water softeners, commercial purified water dispensers, RO membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. The Company provides customized water solutions including residential water solutions, commercial water solutions, public facilities water solutions, industrial water and other special conditions. The Company sells its products domestically in China as well as in overseas markets including Europe, North America and other parts of Asia.

Sector

Environmental Services & Equipment

Calendar

2024-05-15 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Purification & Treatment Equipment

	1st Jan change	Capi.
CANATURE HEALTH TECHNOLOGY CO., LTD.	-15.48%	409M
DONALDSON COMPANY, INC.	+10.59%	8.7B
ORGANO CORPORATION	+29.45%	2.21B
EUREKA FORBES LIMITED	-0.24%	1.18B
CECO ENVIRONMENTAL CORP.	+24.85%	883M
ION EXCHANGE (INDIA) LIMITED	-2.50%	808M
MAYAIR TECHNOLOGY (CHINA) CO., LTD.	-14.90%	600M
NEDERMAN HOLDING AB	+3.40%	594M
MONTANA TECHNOLOGIES CORPORATION	-2.33%	565M
ZHEJIANG FEIDA ENVIRONMENTAL SCIENCE & TECHNOLOGY CO., LTD.	-8.50%	553M

Purification & Treatment Equipment